DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,172,400 | -42.7% | 154,000 | -18.1% | 1.07% | -36.6% |
| Q2 2023 | $5,538,480 | +177.7% | 188,000 | +117.2% | 1.69% | +202.7% |
| Q1 2023 | $1,994,688 | +88.9% | 86,575 | +127.8% | 0.56% | +70.9% |
| Q4 2022 | $1,056,020 | -9.4% | 38,000 | 0.0% | 0.33% | -12.8% |
| Q3 2022 | $1,166,000 | -96.9% | 38,000 | +3298.9% | 0.37% | -5.6% |
| Q2 2022 | $38,000,000 | +363.9% | 1,118 | -97.1% | 0.40% | -78.6% |
| Q1 2022 | $8,192,000 | +607.4% | 38,000 | +46.2% | 1.85% | +615.9% |
| Q4 2021 | $1,158,000 | – | 26,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |